Creative Biolabs Announced New Solutions for T Cell Therapy Development
Industry: Healthcare
Having been immersed in the discovery of gamma delta T cell therapy for years, Creative Biolabs has made great achievements in this field. It is committed to continuing to explore the mysteries of gamma delta T cell therapy in order to make more contributions to the fight against human cancer.
New York, NY (PRUnderground) October 26th, 2022
Warning: strpos(): Empty needle in /home/dev/public_html/wp-content/themes/pru2.0/functions.php on line 363
Due to their direct or indirect antitumor cytotoxicity and strong cytokine production ability, gamma delta (γδ) T cells in cancer immunotherapy have received significant attention over the past decade. Recently, more γδ T cell-based cancer immunotherapy has been developed and revealed effective results, such as adoptive cell therapy and γδ T cell adoptive immunotherapy in combination with immune checkpoint inhibitors. As a reputed and reliable CRO company, Creative Biolabs is actively involved in the development of T cell-based immunotherapy for a variety of tumor types and contributes to advancing the development of T cell-based therapies for cancer treatment by offering comprehensive gamma delta T cell services.
“T cell activation is an essential part in the development of γδ T cell-based immunotherapy and high-standard T cell activation technology ensure the viability of your T cells,” according to a scientist at Creative Biolabs.
Creative Biolabs has spent years developing the best solutions for T cell activation and has assembled a team of experienced scientists who have focused on the research of γδ T cells for decades. The company contributes to providing optimal solutions for γδ T cell activation and expansion, thus supporting the development of γδ T cell-based immunotherapies.
“We have contributed a lot for the optimization of T cell cytotoxicity tests additionally,” added the scientist, “because we are aware of how tests have great impacts on γδ T cell development.”
Creative Biolabs has worked diligently for years to advance γδ T cells and cancer immunotherapy development, and today it can offer a variety of T cell cytotoxicity test services, including the following:
- LDH cytotoxicity test
- Flow cytometry-based cytotoxicity test
- Chromium-51 release assay
- Impedance-based label-free real-time cytotoxicity assay
To learn more about services regarding gamma delta T cell therapy at Creative Biolabs, please visit https://gammadelta-t-therapy.creative-biolabs.com/.
